Details of the Drug Combination

General Information of Drug Combination (ID: DC9J6WW)

Drug Combination Name
Meglumine gadoterate Gadoteridol
Indication
Disease Entry Status REF
Motor Function Phase 4 [1]
Component Drugs Meglumine gadoterate   DM88FNL Gadoteridol   DMRGSKK
Small molecular drug Small molecular drug
2D MOL 2D MOL
3D MOL 3D MOL is unavailable

References

1 ClinicalTrials.gov (NCT04373564) Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
2 Radium 223 dichloride for prostate cancer treatment. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015